21 CFR § 99.105 Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices

§ 99.105 Recipients of information.

Current through Sep 8, 2026 · Read all of Part 99

A manufacturer disseminating information on a new use under this part may only disseminate that information to a health care practitioner, a pharmacy benefit manager, a health insurance issuer, a group health plan, or a Federal or State Government agency.

← § 99.103 Mandatory statements and information.§ 99.201 Manufacturer's submission to the agency. →